Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasiv...
BACKGROUND: Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematica...
The use of imiquimod 5% cream, a topical immunomodulator for the treatment of lentigo maligna (LM) w...
Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsati...
Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsati...
Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is...
Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is...
peer reviewedLentigo maligna is a special form of in situ cutaneous melanoma that develops on the fa...
Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematically review c...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasiv...
BACKGROUND: Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematica...
The use of imiquimod 5% cream, a topical immunomodulator for the treatment of lentigo maligna (LM) w...
Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsati...
Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsati...
Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is...
Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is...
peer reviewedLentigo maligna is a special form of in situ cutaneous melanoma that develops on the fa...
Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematically review c...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
International audienceBackground: Lentigo maligna (LM) is a melanocytic proliferation occurring on p...
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasiv...
BACKGROUND: Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematica...
The use of imiquimod 5% cream, a topical immunomodulator for the treatment of lentigo maligna (LM) w...
DOI
Add to ORKG